[HTML] plos.org

[HTML][HTML] Direct and allosteric inhibition of the FGF2/HSPGs/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule

K Pagano, R Torella, C Foglieni, A Bugatti… - PLoS …, 2012 - journals.plos.org
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …
被引用次数：44 相关文章
[PDF] scienceopen.com

[PDF][PDF] Direct and Allosteric Inhibition of the FGF2/HSPGs

K Pagano, R Torella, C Foglieni, A Bugatti… - FGFR1 Ternary …, 2012 - scienceopen.com
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …
[PDF] academia.edu

[PDF][PDF] Direct and Allosteric Inhibition of the FGF2/HSPGs

K Pagano, R Torella, C Foglieni, A Bugatti… - FGFR1 Ternary …, 2012 - academia.edu
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …
[PDF] semanticscholar.org

[PDF][PDF] Direct and Allosteric Inhibition of the FGF2/HSPGs

K Pagano, R Torella, C Foglieni… - FGFR1 Ternary …, 2012 - pdfs.semanticscholar.org
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …
[PDF] psu.edu

[PDF][PDF] Direct and Allosteric Inhibition of the FGF2/HSPGs

K Pagano, R Torella, C Foglieni, A Bugatti… - FGFR1 Ternary …, 2012 - Citeseer
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …

Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule.

K Pagano, R Torella, C Foglieni, A Bugatti… - PLoS …, 2012 - search.ebscohost.com
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …

Direct and allosteric inhibition of the FGF2/HSPGs/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule

K Pagano, R Torella, C Foglieni, A Bugatti… - PloS …, 2012 - pubmed.ncbi.nlm.nih.gov
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …
[HTML] nih.gov

[HTML][HTML] Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule

K Pagano, R Torella, C Foglieni, A Bugatti… - PLoS ONE, 2012 - ncbi.nlm.nih.gov
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …

Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule

K Pagano, R Torella, C Foglieni, A Bugatti, S Tomaselli… - PLoS ONE, 2012 - go.gale.com
Fibroblast growth factors (FGFs) and their receptors are emerging as promising therapeutic
targets for a wide array of pathologies, including angiogenesis-driven diseases. Several …

Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule

P Katiuscia, T Rubben, F Chiara, B Antonella… - PLOS ONE, 2012 - iris.unipv.it
Fibroblast growth factors (FGFs) are recognized targets for the development of therapies
against angiogenesis-driven diseases, including cancer. The formation of a ternary complex …